BAFF selectively enhances the survival of plasmablasts generated from human memory B cells

Journal of Clinical Investigation

Volumn 112, Issue 2, 2003, Pages 286-297

  Avery, Danielle T ^a   Kalled, Susan L ^b   Ellyard, Julia I ^a,c   Ambrose, Christine ^b   Bixler, Sarah A ^b   Thien, Marilyn ^a,c   Brink, Robert ^a   MacKay, Fabienne ^d   Hodgkin, Philip D ^e   Tangye, Stuart G ^a,c  

^a CENTENARY INSTITUTE   (Australia)

^b BIOGEN   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL MATURATION ANTIGEN; BAFF RECEPTOR; CD40 LIGAND; IMMUNOGLOBULIN; PROTEIN BAFF; RECEPTOR; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; ANP32B PROTEIN, HUMAN; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; CD38 ANTIGEN; CD38 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; NEUROPEPTIDE; NUCLEAR PROTEIN; TNFRSF13C PROTEIN, HUMAN; TNFRSF17 PROTEIN, HUMAN; TNFSF13B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BLAST CELL; CELL INTERACTION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; MEMORY CELL; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; T LYMPHOCYTE; APOPTOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; SPLEEN; TIME;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD38; APOPTOSIS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-CELL MATURATION ANTIGEN; B-LYMPHOCYTES; CD40 LIGAND; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL SEPARATION; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; INTERLEUKIN-2; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NEUROPEPTIDES; NUCLEAR PROTEINS; PROTEIN BINDING; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85047690330     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI18025     Document Type: Article

References (60)

1. Van Kooten, C., and Banchereau, J. 1996. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61:1-77.
2. Liu, Y.J., and Banchereau, J. 1996. The paths and molecular controls of peripheral B-cell development. The Immunologist. 4:55-66.
3. Agematsu, K., et al. 1998. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood. 91:173-180.
4. Stuber, E., Neurath, M., Calderhead, D., Fell, H.P., and Strober, W. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity. 2:507-521.
5. Aversa, G., Punnonen, J., and de Vries, J.E. 1993. The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177:1575-1585.
6. Garrone, P., et al. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182:1265-1273.
7. Cerutti, A., et al. 1998. CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells. Immunity. 9:247-256.
8. Jumper, M.D., Nishioka, Y., Davis, L.S., Lipsky, P.E., and Meek, K. 1995. Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands. J. Immunol. 155:2369-2378.
9. Schneider, P., et al. 1999. BAFF, a novel ligand of the tumor necrosis Factor family, stimulates B cell growth. J. Exp. Med. 189:1747-1756.
10. Moore, P.A., et al. 1999. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 285:260-263.
11. Shu, H.B., Hu, W.H., and Johnson, H. 1999. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukoc. Biol. 65:680-683.
12. Mukhopadhyay, A., Ni, J., Zhai, Y., Yu, G.L., and Aggarwal, B.B. 1999. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J. Biol. Chem. 274:15978-15981.
13. Thompson, J.S., et al. 2000. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 192:129-135.
14. Schiemann, B., et al. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111-2114.
15. Schneider, P., et al. 2001. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J. Exp. Med. 194:1691-1697.
16. Mackay, F., et al. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1697-1710.
17. Khare, S.D., et al. 2000. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl. Acad. Sci. U. S. A. 97:3370-3375.
18. Gross, J.A., et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 404:995-999.
19. Groom, J., et al. 2002. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109:59-68. doi:10.1172/JCI200214121.
20. Cheema, G.S., Roschke, V., Hilbert, D.M., and Stohl, W. 2001. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44:1313-1319.
21. Zhang, J., et al. 2001. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166:6-10.
22. Batten, M., et al. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192:1453-1466.
23. Do, R.K., et al. 2000. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192:953-964.
24. Mackay, F., and Browning, J.L. 2002. BAFF: a fundamental survival factor for B cells. Nat. Immunol. 2:465-475.
25. Shu, H.B., and Johnson, H. 2000. B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1. Proc. Natl. Acad. Sci. U. S. A. 97:9156-9161.
26. Thompson, J.S., et al. 2001. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 293:2108-2111.
27. Yan, M., et al. 2001. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11:1547-1552.
28. Hatzoglou, A., et al. 2000. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J. Immunol. 165:1322-1330.
29. Claudio, E., Brown, K., Park, S., Wang, H., and Siebenlist, U. 2002. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3:958-965.
30. von Bulow, G.U., and Bram, R.J. 1997. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science. 278:138-141.
31. Gras, M.P., et al. 1990. BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int. Immunol. 7:1093-1106.
32. Xu, S., and Lam, K.P. 2001. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol. Cell. Biol. 21:4067-4074.
33. Yan, M., et al. 2001. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2:638-643.
34. Lentz, V.M., Hayes, C.E., and Cancro, M.P. 1998. Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J. Immunol. 160:3743-3747.
35. Tangye, S.G., van de Weerdt, B.C.M., Avery, D.T., and Hodgkin, P.D. 2002. CD84 is upregulated on a major population of human memory B cells and recruits the SH2-domain containing proteins SAP and EAT-2. Eur. J. Immunol. 32:1640-1649.
36. Tangye, S.G., Avery, D.T., and Hodgkin, P.D. 2003. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J. Immunol. 170:261-269.
37. Tangye, S.G., Liu, Y.J., Aversa, G., Phillips, J.H., and de Vries, J.E. 1998. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188:1691-1703.
38. Tangye, S.G., Avery, D.T., Deenick, E.K., and Hodgkin, P.D. 2003. Intrinsic differences in the proliferation of naïve and memory human B cells as a mechanism for enhanced secondary immune responses. J. Immunol. 170:686-694.
39. Hasbold, J., et al. 1999. Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol. Cell Biol. 77:516-522.
40. Arpin, C., et al. 1995. Generation of memory B cells and plasma cells in vitro. Science. 268:720-722.
41. Terstappen, L.W., Johnsen, S., Segers-Nolten, I.M., and Loken, M.R. 1990. Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood. 76:1739-1747.
42. Dai, C., and Krantz, S.B. 1999. Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93:3309-3316.
43. Defrance, T., et al. 1987. B cell growth-promoting activity of recombinant human interleukin 4. J. Immunol. 139:1135-1141.
44. Itoh, K., and Hirohata, S. 1995. The role of IL-10 in human B cell activation, proliferation, and differentiation. J. Immunol. 154:4341-4350
45. Jego, G., et al. 1999. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood 94:701-712.
46. Balázs, M., Martin, F., Zhou, T., and Kearney, J.F. 2002. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity. 17:341-352.
47. Amanna, I.J., Clise-Dwyer, K., Nashold, F.E., Hoag, K.A., and Hayes, C.E. 2001. Cutting edge: A/WySnJ transitional B cells overexpress the chromosome 15 proapoptotic Blk gene and succumb to premature apoptosis. J. Immunol. 167:6069-6072.
48. Litinskiy, M.B., et al. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:822-829.
49. Briere, F., et al. 1994. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J. Clin. Invest. 94:97-104.
50. Conley, M.E., and Cooper, M.D. 1981. Immature IgA B cells in IgA-deficient patients. N. Eng. J. Med. 305:495-497.
51. Urashima, M., Chauhan, D., Uchiyama, H., Freeman, G.J., and Anderson, K.C. 1995. CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood. 85:1903-1912.
52. Tarte, K., et al. 2002. Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. Blood. 100:1113-1122.
53. Dunn-Walters, D.K., Isaacson, P.G., and Spencer, J. 1995. Analysis of murations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J. Exp. Med. 182:559-566.
54. Kawano, M.M., Mihara, K., Huang, N., Tsujimoto, T., and Kuramoto, A. 1995. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood. 85:487-494.
55. Nardelli, B., et al. 2001. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood. 97:198-204.
56. Craxton, A., Magaletti, D., Ryan, E.J., and Clark, E.A. 2003. Macrophage and dendritic-cell dependent regulation of human B cell proliferation requires the TNF family ligand BAFF. Blood. 101:4464-4471.
57. Lederman, S., et al. 1992. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J. Immunol. 149:3817-3826.
58. Casamayor-Palleja, M., Khan, M., and MacLennan, I.C. 1995. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J. Exp. Med. 181:1293-1301.
59. Xu, L.G., Wu, M., Hu, J., Zhai, Z., and Shu, H.B. 2002. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J. Leukoc. Biol. 72:410-416.
60. Beebe, A.M., Cua, D.J., and de Waal Malefyt, R. 2002. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev. 13:403-412.